Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Alcon Settles Patent Dispute with J&J Vision for $199 Million
Alcon Inc., a global leader in eye care, has reached a settlement agreement with J&J Surgical Vision to resolve their legal proceedings regarding femtosecond laser-assisted cataract surgery devices, including Alcon’s LenSx® device. Alcon acquired the LenSx device as part of…
Complement Therapeutics Begins i-GAIN Study
Complement Therapeutics has made an announcement about the enrollment of the first participant in the i-GAIN study, a research project aimed at gaining insight into geographic atrophy (GA) – a condition that results in irreversible blindness and is caused by…
Regeneron’s EYLEA® Injection Approved for ROP
Regeneron Pharmaceuticals announced that the FDA granted its approval for the use of EYLEA® (aflibercept) Injection as a treatment option for preterm infants suffering from retinopathy of prematurity (ROP). This marks the first time that EYLEA has received approval for…
Endogena Receives FDA Fast Tract Designation for RP
Endogena Therapeutics announced that the US FDA has designated the investigation of its drug EA-2353 for the treatment of retinitis pigmentosa (RP) as a Fast Track development program. This process speeds up the availability of new drugs for serious conditions…
Nidek Introduces Cube Alpha Ophthalmic Surgical System
Nidek has introduced the Cube α ophthalmic surgical system, which is designed to incorporate new ultrasound technology for enhanced phacoemulsification. Nidek reports that the Cube α features Gyro torsional technology within its compact design. The torsional ultrasound oscillation enhances the…
Nidek and Hoya Form Global Partnership
Hoya Vision Care and Nidek have entered a global partnership that would give Hoya’s clients access to Nidek’s optical goods, services, and equipment through both regional distributors. Financial terms of the deal were not disclosed. According to Nidek, the partnership’s…
Smart Contact Lens That Diagnoses and Treats Glaucoma
A research team at POSTECH has recently developed a wireless theranostic smart contact lens that combines an IOP sensor and a flexible drug delivery system to control IOP measurement and drug administration in glaucoma. Glaucoma is a common eye disease…
FDA Approves Bausch + Lomb’s Photodynamic Laser
Bausch + Lomb and Modulight Corporation, a biomedical laser company, today announced that the FDA has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) photodynamic therapy (PDT) for the treatment of patients…
Intraocular Lens Market to Reach $6.7 Billion
The global intraocular lens market is projected to grow from its current valuation of $4.1 billion to $6.7 billion by the end of 2032, according to a recent report by Fact Market Research (FMR). The market is expected to expand…
Regeneron Wins Patens Case Against Novartis
Regeneron Pharmaceuticals Inc. has won a patent case against Novartis AG in a U.S. court, protecting the company’s drug delivery system for its eye drug Eylea. The US Patent Trial and Appeal Board ruled in favor of Regeneron, stating that…